Single-cell transcriptomics identifies CD44 as a marker and regulator of 
endothelial to haematopoietic transition

Oatley, Morgan; Bölükbası, Özge Vargel; Svensson, Valentine; Shvartsman, Maya; Ganter, Kerstin; Zirngibl, Katharina; Pavlovich, Polina V.; Milchevskaya, Vladislava; Foteva, Vladimira; Natarajan, Kedar N.; Baying, Bianka; Benes, Vladimir; Patil, Kiran R.; Teichmann, Sarah A.; Lancrin, Christophe

doi:org/10.1038/s41467-019-14171-5

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Single-cell transcriptomics identifies CD44 as a marker and regulator of endothelial to haematopoietic transition

MPS-Authors

Pavlovich, Polina V.
Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Resource

https://www.nature.com/articles/s41467-019-14171-5
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Oatley, M., Bölükbası, Ö. V., Svensson, V., Shvartsman, M., Ganter, K., Zirngibl, K., et al. (2020). Single-cell transcriptomics identifies CD44 as a marker and regulator of endothelial to haematopoietic transition. Nature Communications, 11, 586. doi:org/10.1038/s41467-019-14171-5.

Cite as: https://hdl.handle.net/21.11116/0000-0007-E6BE-0

Abstract

The endothelial to haematopoietic transition (EHT) is the process whereby haemogenic endothelium differentiates into haematopoietic stem and progenitor cells (HSPCs). The intermediary steps of this process are unclear, in particular the identity of endothelial cells that give rise to HSPCs is unknown. Using single-cell transcriptome analysis and antibody screening, we identify CD44 as a marker of EHT enabling us to isolate robustly the different stages of EHT in the aorta-gonad-mesonephros (AGM) region. This allows us to provide a detailed phenotypical and transcriptional profile of CD44-positive arterial endothelial cells from which HSPCs emerge. They are characterized with high expression of genes related to Notch signalling, TGFbeta/BMP antagonists, a downregulation of genes related to glycolysis and the TCA cycle, and a lower rate of cell cycle. Moreover, we demonstrate that by inhibiting the interaction between CD44 and its ligand hyaluronan, we can block EHT, identifying an additional regulator of HSPC development.